Search

everythinglearnresearchcommunity

for

Search:↓

A 62-year-old woman with hair loss and scalp itching was diagnosed with lichen planopilaris, treated initially with topical corticosteroids, and other possible treatments include systemic steroids, antimalarials, and more.

Detailed history and physical examination are crucial for diagnosing hair loss.

The document concludes that proper diagnosis and a combination of medical, hair-care, and surgical treatments are important for managing alopecia in black women.

Some African American women's central scalp hair loss is linked to genetics and past fungal scalp infections, with more research needed on other causes.

Small white dots on the scalp seen with a dermoscope correspond to sweat ducts and vary with different hair disorders.

Frequent use of chemical hair relaxants is linked to increased scarring hair loss in Nigerian women.

The document explains different types of hair loss, their causes, and treatments, and suggests future research areas.

A scale was made to measure hair loss severity in African American women.

The document concludes that accurate diagnosis and treatment of scalp itch require differentiating between various conditions using a proposed five-step evaluation process.

Hair transplantation may work for some types of scarring alopecia, but results vary and more research is needed.

Using CD123 to detect certain immune cells helps diagnose a type of hair loss condition.

Nonscarring alopecia has higher hair density than scarring alopecia, and hair density can help diagnose the type of alopecia.

Proper education can prevent traction alopecia in women of color.

Hair loss in people with darker skin has unique challenges and requires careful diagnosis and treatment.

Pigmented casts are common in several hair loss conditions and can help diagnose specific types of alopecia.

Finasteride's effectiveness for frontal fibrosing alopecia is uncertain.

Lichen planopilaris can be triggered by prolonged scalp traction and can be treated with corticosteroids.

The document concludes that patients with skin of color need specialized dermatological care and education to manage unique skin conditions effectively.

Certain mutations in the PADI3 gene may increase the risk of developing a type of scarring hair loss common in women of African descent.

Three characteristics of plasmacytoid dendritic cells help tell apart lupus-related hair loss from LPP.

Trichoscopy helps tell apart Frontal Fibrosing Alopecia and Lichen planopilaris by showing different hair and scalp features.

Enzymes that change arginine to citrulline are important for skin barrier and hair formation, and their malfunction can lead to skin conditions and hair disorders.

Scalp biopsies greatly improved diagnosis and treatment for Black women with unclear alopecia.

Dermatologists often neglect hair disorders due to complexity and lack of clear treatments, impacting patient care and highlighting the need for better education and interest in this area.

Alopecia causes hair loss and should be treated early, especially scarring types where hair cannot regrow.

Classifying curl patterns might help doctors assess and treat hair loss better.

A woman with CCCA has hair loss due to factors like straighteners and tight hairstyles, and treatments include steroids and avoiding certain hair products.

L'Oréal's research and workshops have advanced understanding and tailored cosmetics for African hair and skin.

Minoxidil may help with hair regrowth and disease stabilization in scarring alopecia, but side effects vary, needing more research for consistent safety and effectiveness.

The document concludes that more local research on African skin and hair is needed despite increased scientific output from Sub-Saharan Africa.